Acquisitions (Tables)

9 Months Ended

Sep. 30, 2018

Schedule of proforma results

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2018		2017		2018		2017
Revenue	$	57,343	$	43,572	$	159,764	$	126,326
Net income (loss)		11,278		(1,216)		(35,816)		(5,753)
Net income (loss) per share attributable to common stockholders, basic		0.59		(0.07)		(1.88)		(0.34)
Net income (loss) per share attributable to common stockholders, diluted		0.51		(0.07)		(1.88)		(0.34)

Mediture

Schedule of purchase price consideration

Cash consideration at closing, net of post-closing adjustments	$	17,452
Stock consideration at closing		3,595
Total fair value of acquisition consideration	$	21,047

Schedule of allocation of the purchase price based on the estimated fair values of the assets acquired and liabilities

Cash	$	2,427
Accounts receivable		898
Prepaid expenses and other current assets		136
Property and equipment		219
Trade name		300
Developed technology		2,300
Client relationships		4,400
Non-competition agreement		1,300
Goodwill		13,167
Total assets acquired	$	25,147
Accrued expenses and other liabilities		(3,811)
Trade accounts payable		(112)
Other long-term liabilities		(177)
Total purchase price	$	21,047

Peak PACE Solutions

Schedule of purchase price consideration

Cash consideration at closing, net of post-closing adjustments	$	7,563
Estimated fair value of contingent consideration		1,620
Total fair value of acquisition consideration	$	9,183

Schedule of allocation of the purchase price based on the estimated fair values of the assets acquired and liabilities

Cash	$	606
Property and equipment		84
Trade name		290
Client relationships		5,220
Non-competition agreement		50
Goodwill		3,559
Total assets acquired	$	9,809
Accrued expenses and other liabilities		(626)
Total purchase price, including contingent consideration of $1,620	$	9,183

SinfoniaRx

Schedule of purchase price consideration

Cash consideration at closing, net of post-closing adjustments	$	34,492
Stock consideration at closing		11,541
Estimated fair value of contingent consideration		38,092
Total fair value of acquisition consideration	$	84,125

Schedule of allocation of the purchase price based on the estimated fair values of the assets acquired and liabilities

Cash	$	218
Accounts receivable		8,309
Prepaid expenses and other current assets		1,056
Property and equipment		1,419
Other assets		127
Trade name		4,776
Developed technology		13,291
Client relationships		20,265
Non-competition agreement		4,752
Goodwill		52,507
Total assets acquired	$	106,720
Accrued expenses and other liabilities		(3,819)
Trade accounts payable		(8,868)
Debt assumed		(675)
Deferred income tax liability, net		(9,233)
Total purchase price, including contingent consideration of $38,092	$	84,125